Renamic Neo with LiveSupport Software
Renamic Neo with LiveSupport Software
Image
Women at BIOTRONIK
greyblue
Four of Our Most Inspiring Leaders Talk About the Most Important Lessons From Their Careers
bottom_right
On
greyblue
s
Women at BIOTRONIK
Image
Orsiro® Mission DES
pink
<p>FDA Approved<p>
<p>Better Deliverability</p>
<p>Outstanding Outcomes</p>
<p>Better Deliverability</p>
<p>Outstanding Outcomes</p>
bottom_right
On
pink
s
Image
BIOMONITOR IIIm Receives Prestigious Industry Award
grey
<p>Maximized Precision. Only Insertable Monitor with Body Temperature Sensor.</p>
top_right
Off
lime
l
BIOMONITOR IIIm Receives Prestigious Industry Award
Maximized Precision. Only Insertable Monitor with Body Temperature Sensor.
Image
DX Technology</br>True Atrial Signal.</br>No Atrial Lead.
none
<p>DR Smart. VR Simple. CRT Capable</p>
bottom_left
On
green
s
Image
BIOTRONIK Announces Collaboration with AliveCor
none
bottom_left
On
lime
s
BIOTRONIK Announces Collaboration with AliveCor
Excellence For Life.
Prof. Max Schaldach founded BIOTRONIK 60 years ago with one focus, changing lives. Our unique revolutionary innovations and technology span cardiac rhythm management, vascular intervention and electrophysiology. BIOTRONIK has been developing trusted and innovative cardiovascular and endovascular solutions. Our innovations enable care that saves and improves the lives of patients diagnosed with heart and blood vessel diseases. With global headquarters in Berlin, Germany and U.S. operations in New York City and Lake Oswego, Oregon, we’re proud to focus on what really matters—our partnerships with healthcare professionals to positively impact patient care. We do this by investing in research and development while never losing sight of the importance of quality and reliability.
ORSIRO® MISSION DRUG-ELUTING STENT SYSTEM
Better Deliverability. Outstanding Patient Outcomes.
BIOTRONIK is a privately owned, global medical device company with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases. Patient well being is our top priority and has been for more than 50 years.